GlassScriptPrepare for your visit
Ashley M Crane
Ophthalmology · Tampa, FL · NPI 1225460371
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$37,683.44
in general payments reported to CMS, 2019-2025 · $8,515 in 2025
The $8,515 reported for 2025 was more than what 95% of Ophthalmology providers received nationally (typical 2025 total: $384).
Who reported paying
General payments only, top 6 by amount.
- Abbvie INC. $8,873.28
- Ocular Therapeutix, INC. $7,050.70
- Genentech USA, INC. $6,730.23
- Regeneron Healthcare Solutions, INC. $2,017.64
- Eyepoint US, INC. $1,926.59
- Alimera Sciences, INC. $1,634.17
Drugs and devices associated with these payments
Ozurdex Eyp-1901 Vabysmo Eylea Hd Constellation Izervay Iheezo Syfovre Eylea Triesence Iluvien Dextenza
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Ashley Crane listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/55185/ashley-m-crane